Neurologic Injuries in Adults With Urea Cycle Disorders
Assessing Neural Mechanisms of Injury in Inborn Errors of Urea Metabolism Using Structural MRI, Functional MRI, and Magnetic Resonance Spectroscopy
Sponsor: Andrea Gropman
A observational or N/A phase clinical study on Brain Diseases, Metabolic, Inborn and Ornithine Transcarbamylase Deficiency, this trial is completed. The trial is conducted by Andrea Gropman and has accumulated 11 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 6 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Mar 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Mar 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Mar 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Andrea Gropman
- National Center for Research Resources (NCRR)
- Office of Rare Diseases (ORD)
- Rare Diseases Clinical Research Network
For direct contact, visit the study record on ClinicalTrials.gov .